In order to determine whether Wnt-11 protein levels are elevated in patient tumours, we used anti-Wnt-11 antibodies to localise Wnt-11 expression in sections taken from human prostate and prostate tumour tissue (Figure 1). The gene discussed is WNT11; the disease is prostate neoplasm.